Skip to main content
Premium Trial:

Request an Annual Quote

Accelrys Reports 2 Percent Increase in Fiscal Q2 Revenues, Net Income Declines

NEW YORK (GenomeWeb News) – Accelrys today reported a 2 percent uptick in revenues for the second quarter of its 2009 fiscal year, accompanied by a 25 percent dip in net profit for the period.
The scientific software firm’s revenue for the quarter ended Sept. 30, 2008, rose slightly to $20.1 million from $19.7 million for the same quarter of the previous year.
Product development costs declined 11 percent to $3.8 million from $4.3 million in the third quarter of 2007, while sales and marketing costs rose 15 percent to $8.2 million from $7.1 million.
Net income fell to $1.2 million, or $.04 per share, from $1.6 million, or $.06 per share, for the same quarter of the previous year.
As of Sept. 30, Accelrys had $70.3 million in cash, cash equivalents, and marketable securities.
Mark Emkjer, president and CEO of Accelrys, said in a statement that the company’s financial results were “in line with our expectations.”

Filed under

The Scan

Dropped Charges

The US Justice Department has dropped visa fraud charges against five Chinese researchers, according to the Wall Street Journal.

More Kids

The Associated Press says Moderna is expanding its SARS-CoV-2 vaccine study to included additional children and may include even younger children.

PNAS Papers on Rat Clues to Human Migration, Thyroid Cancer, PolyG-DS

In PNAS this week: ancient rat genome analysis gives hints to human migrations, WDR77 gene mutations in thyroid cancer, and more.

Purnell Choppin Dies

Purnell Choppin, a virologist who led the Howard Hughes Medical Institute, has died at 91, according to the Washington Post.